These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20661556)
1. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556 [TBL] [Abstract][Full Text] [Related]
2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease. Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121 [TBL] [Abstract][Full Text] [Related]
3. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions. Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000 [TBL] [Abstract][Full Text] [Related]
4. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study. Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202 [TBL] [Abstract][Full Text] [Related]
5. Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. Hyun SH; Choi JY; Lee KH; Choe YS; Kim BT J Nucl Med; 2011 Apr; 52(4):547-50. PubMed ID: 21421711 [TBL] [Abstract][Full Text] [Related]
6. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887 [TBL] [Abstract][Full Text] [Related]
7. Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography. Cho SH; Kim SW; Kim WC; Park JM; Yoo IeR; Kim SH; Oh ST World J Gastroenterol; 2013 Jun; 19(22):3453-8. PubMed ID: 23801838 [TBL] [Abstract][Full Text] [Related]
8. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis. Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124 [TBL] [Abstract][Full Text] [Related]
9. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? van Hoeij FB; Keijsers RG; Loffeld BC; Dun G; Stadhouders PH; Weusten BL Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):66-71. PubMed ID: 25139518 [TBL] [Abstract][Full Text] [Related]
10. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347 [TBL] [Abstract][Full Text] [Related]
11. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [ Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982 [TBL] [Abstract][Full Text] [Related]
12. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543 [TBL] [Abstract][Full Text] [Related]
13. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845 [TBL] [Abstract][Full Text] [Related]
14. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas. Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998 [TBL] [Abstract][Full Text] [Related]
15. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765 [TBL] [Abstract][Full Text] [Related]
16. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not? Takanami K; Kaneta T; Morimoto R; Satoh F; Nakamura Y; Takase K; Takahashi S Ann Nucl Med; 2014 Feb; 28(2):145-53. PubMed ID: 24272068 [TBL] [Abstract][Full Text] [Related]
17. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [TBL] [Abstract][Full Text] [Related]
18. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans. Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193 [TBL] [Abstract][Full Text] [Related]
19. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]